Home » Topics » Regulatory » Patents

Patents
RSS

Synthelabo claims mixed and specific dopamine receptor ligands

Feb. 3, 1998

Somatostatin receptor ligands synthesized by Novo Nordisk

Feb. 2, 1998

AMPA receptor antagonists disclosed by Pfizer

Feb. 2, 1998

New anticonvulsants under study at Bristol-Myers Squibb

Feb. 2, 1998

2,4-Diaminopyrimidines claimed as imaging agents, potentially useful in psychotic disorders

Feb. 2, 1998

Synaptic develops selective human alpha1A-receptor antagonists

Feb. 2, 1998

Roche discloses inhibitors of bacterial dihydrofolate reductase

Feb. 2, 1998

Vitamin D3 analogues from Roche for skin, neoplastic diseases

Feb. 2, 1998

BMS prepares MTP inhibitors for atherosclerosis and related diseases

Feb. 2, 1998

Roche patents vitamin D analogues for osteoporosis

Jan. 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...